Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiujiuchang is a Traditional Chinese Medicine (TCM) hospital preparation developed by The First Affiliated Hospital of Zhengzhou University for the management of chemotherapy-induced diarrhea (CID). It is formulated to address the gastrointestinal toxicity often encountered during cancer treatment, particularly with agents like irinotecan or fluoropyrimidines. According to TCM theory, the formula works by tonifying the spleen and warming the kidney to restore intestinal function and arrest diarrhea. Clinical evaluations have demonstrated its potential to reduce the frequency and severity of diarrheal episodes, thereby improving patient adherence to chemotherapy regimens and overall quality of life. It is typically administered orally as granules or a decoction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiujiuchang.